Sam-A Pharm. Co. Ltd
Sam-A Pharm. Co., Ltd operates as a pharmaceutical company in South Korea. The company offers a range of pharmaceutical products in the areas of respiratory, anti-biotics, anti-virals, anti-histamines, anti-fungals, dermatology, pain/inflammation, gastrointestinal, cardiovascular, metabolism, urological, and steroids, as well as psychotropic agents; and OTC products in the areas of respiratory, a… Read more
Sam-A Pharm. Co. Ltd - Asset Resilience Ratio
Sam-A Pharm. Co. Ltd (009300) has an Asset Resilience Ratio of 34.37% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2009–2024)
This chart shows how Sam-A Pharm. Co. Ltd's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Sam-A Pharm. Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩84.58 Billion | 34.37% |
| Total Liquid Assets | ₩84.58 Billion | 34.37% |
Asset Resilience Insights
- Very High Liquidity: Sam-A Pharm. Co. Ltd maintains exceptional liquid asset reserves at 34.37% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Sam-A Pharm. Co. Ltd Industry Peers by Asset Resilience Ratio
Compare Sam-A Pharm. Co. Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
AGP Ltd
KAR:AGP |
Pharmaceuticals | 0.71% |
|
Sam Chun Dang Pharm. Co. Ltd
KQ:000250 |
Pharmaceuticals | 4.82% |
|
DongKoo Bio&Pharma Co. Ltd
KQ:006620 |
Pharmaceuticals | 4.28% |
|
NatureCell Co.Ltd
KQ:007390 |
Pharmaceuticals | 0.00% |
|
Kyung Dong Pharmaceutical Co. Ltd
KQ:011040 |
Pharmaceuticals | 5.22% |
|
WooGene B&G Co. Ltd
KQ:018620 |
Pharmaceuticals | 3.35% |
|
Oscotec Inc
KQ:039200 |
Pharmaceuticals | 61.00% |
|
EstechPharma Co. Ltd
KQ:041910 |
Pharmaceuticals | 9.64% |
Annual Asset Resilience Ratio for Sam-A Pharm. Co. Ltd (2009–2024)
The table below shows the annual Asset Resilience Ratio data for Sam-A Pharm. Co. Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 27.74% | ₩68.99 Billion | ₩248.73 Billion | -6.46pp |
| 2023-12-31 | 34.20% | ₩79.10 Billion | ₩231.31 Billion | -3.88pp |
| 2022-12-31 | 38.07% | ₩77.37 Billion | ₩203.20 Billion | +10.07pp |
| 2021-12-31 | 28.01% | ₩52.98 Billion | ₩189.17 Billion | -7.09pp |
| 2020-12-31 | 35.09% | ₩63.91 Billion | ₩182.11 Billion | +18.46pp |
| 2019-12-31 | 16.63% | ₩31.73 Billion | ₩190.78 Billion | -8.69pp |
| 2018-12-31 | 25.32% | ₩43.99 Billion | ₩173.69 Billion | -1.71pp |
| 2017-12-31 | 27.04% | ₩45.41 Billion | ₩167.97 Billion | +3.73pp |
| 2016-12-31 | 23.30% | ₩37.81 Billion | ₩162.27 Billion | +9.45pp |
| 2015-12-31 | 13.85% | ₩21.18 Billion | ₩152.91 Billion | -8.19pp |
| 2014-12-31 | 22.04% | ₩32.15 Billion | ₩145.86 Billion | -3.93pp |
| 2012-12-31 | 25.97% | ₩37.61 Billion | ₩144.79 Billion | +10.01pp |
| 2011-12-31 | 15.96% | ₩22.00 Billion | ₩137.86 Billion | +10.68pp |
| 2010-12-31 | 5.28% | ₩6.79 Billion | ₩128.75 Billion | +1.83pp |
| 2009-12-31 | 3.45% | ₩3.83 Billion | ₩111.10 Billion | -- |